First Affiliated Hospital of Wenzhou Medical University
206
54
61
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.5%
3 terminated/withdrawn out of 206 trials
87.0%
+0.5% vs industry average
14%
28 trials in Phase 3/4
0%
0 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (206)
Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy
Role: collaborator
The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
Role: collaborator
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
Role: lead
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety
Role: lead
The Chinese Familial Alzheimer's Network
Role: collaborator
China Cognition and Aging Study
Role: collaborator
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
Role: lead
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Role: collaborator
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
Role: collaborator
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
Role: lead
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
Role: collaborator
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Role: lead
Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
Role: collaborator
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
Role: lead
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Role: collaborator
Improving the Quality of Coronary Artery Bypass Grafting
Role: collaborator
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
Role: lead
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
Role: collaborator
Intelligent Precision Knee Preservation System for Knee Osteoarthritis
Role: lead
Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
Role: collaborator